Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: An umbrella trial

Paul Hutton, Christopher Taylor, James Kelly, Richard Emsley, Anvita Vikram, Candy Ho Alexander, Andrea McCann, David Saddington, Emma Eliasson, Joseph Burke, Sean Harper, Thanos Karatzias, Peter Taylor, Andrew Watson, Nadine Dougall, Jill Stavert, Suzanne O'Rourke, Angela Glasgow, Regina Murphy, Karen PalmerNosheen Zaidi, Polly Bidwell, Jemma Pritchard, Lucy Carr, Amanda Woodrow

Research output: Contribution to journalArticlepeer-review

7 Downloads (Pure)

Abstract

Introduction
Many individuals with schizophrenia-spectrum disorder (‘psychosis’) lack capacity to make decisions about psychiatric treatment (‘incapacity’), however we lack robust evidence from clinical trials on interventions to improve it. To accelerate their development, we tested whether an ‘umbrella’ trial was feasible. This involved running multiple randomised controlled ‘interventionist-causal’ trials (IC-RCTs) concurrently. Each tested the effect on incapacity of targeting an individual psychological mechanism.
Methods
We did 3 assessor-blind, multi-site, pilot IC-RCTs. Each compared 6 sessions of psychological therapy for either self-stigma (SS), low self-esteem (SE) or the jumping-to-conclusions (JTC) bias, to 6 sessions of collaborative assessment of the causes of incapacity (control). Adults with psychosis, incapacity and ≥1 target mechanism could participate. Primary outcomes were recruitment feasibility, and data retention on the MacArthur Competence Assessment Tool-Treatment (MacCAT-T).
Results
We recruited 57 participants and performed 60 randomisations (3 patients participated in 2 trials); 82 % provided post-treatment data. Standardised mean differences (Hedges' g) for MacCAT-T ‘understanding’ were g = 0.35 (SS; 95 % CI −0.51, 1.22), g = 0.41 (JTC; −0.55, 1.38) and g = 0.74 (SE; −0.73, 2.21), with positive values favouring treatment. For ‘reasoning’, they were −0.20 (SS; −1.05, 0.66), 0.79 (JTC; −0.20, 1.79) and 0.79 (SE −0.69, 2.27). For ‘appreciation’ they were −0.39 (SS; −1.25, 0.48), 1.76 (JTC; 0.62, 2.90) and 0.57 (SE; −0.87, 2.02). Four control participants had 9 serious adverse events between randomisation and post-treatment; two intervention participants had 2.
Discussion
An umbrella trial of psychological interventions to improve capacity in psychosis is feasible. A definitive trial is warranted.
Original languageEnglish
Pages (from-to)184-197
JournalSchizophrenia Research.
Volume282
Early online date3 Jul 2025
DOIs
Publication statusPublished - 1 Aug 2025

Keywords

  • Schizophrenia
  • Psychosis
  • Patient Autonomy
  • Umbrella Trial
  • Supported Decision-making
  • Randomised Controlled Trial

Fingerprint

Dive into the research topics of 'Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: An umbrella trial'. Together they form a unique fingerprint.

Cite this